Click on image to view larger version.

Figure 6 Threshold Risk of VLST in DES as a Function of the RR Reduction in Clinical Restenosis With DES

Current DES reduce target vessel revascularization (TVR) by 65%. If the relative risk (RR) reduction in TVR with DES was lower than 65%, then the annual incremental risk of VLST in DES that preserved DES benefit over BMS was decreased. Abbreviations as in Figures 1 and 2.